ClinicalTrials.gg
CompletedNCT05780047Updated May 14, 2024Results posted

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals in Adults of Child-Bearing Age

An interventional study of Mail-in Urine Test for EDCs in Endocrine Disrupting Chemicals, Environmental Exposure and Health Literacy, sponsored by Million Marker Wellness, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-14.

Sponsored by Million Marker Wellness, Inc. · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled May 2022, registered Feb 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
434
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Literacy with a site in United States — 19 open to participants now, 22 under way, none of them phase 3. Literacy · United States.

Enrollment
7th of 74
434 · median 105
Started
2022
with 6 others
No phase
70 of 79
15 open now
Registered
56th of 79
by date

Among the 79 studies in Literacy with a site in United States, this one is the 7th largest by enrollment of the 74 interventional ones that give a count, is one of 7 that started in 2022, is one of 70 with no phase, and was the 56th registered.

Literacy

203 studies on the registry are indexed under Literacy; 69 are open to participants now.

Browse Literacy studies →

Open to participants now

19 of the 79 studies in Literacy with a site in United States are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 29 Literacy studies recruiting now, 9 (31%) set no upper age limit and 17 (59%) stop at 75 or younger; 15 take children under 18; 19 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Literacy with a site in United States, or all of them as a file.
02

Study summary

The goal of this intervention study is to determine to what extent the Million Marker (MM) program reduces users' endocrine disruption chemical (EDC) exposure levels and changes their environmental health awareness and behaviors. The main questions it aims to answer are:

  • Can the investigators see a reduction in EDC levels in participants' urine samples after using the MM Detect and Detox kit?
  • Can the investigators see a change in participants' environmental health literacy, knowledge, and behaviors after using MM's products and services?
  • How can Million Marker improve their app and platform to improve the user experience? Participants will collect their urine pre- and post-intervention, and will take a comprehensive exposure survey (via the MM app) before sending back their samples. This exposure survey will ask about participant's product use, diet, and lifestyle behaviors. Participants will also fill out surveys pre- and post-intervention assessing their perception of environmental health, as well as usability of the platform.
Read the detailed description

Exposures to endocrine disrupting chemicals (EDCs) have been linked to chronic diseases and conditions including breast cancer, metabolic syndrome, diabetes, and infertility. Timing of exposure, especially during pregnancy, may have a lifelong impact on the fetus, including neurodevelopmental problems and asthma. However, there have been no tools to allow those in the preconception, conception, and pregnancy stages to assess EDC exposures to ensure a healthy pregnancy and normal child development. Million Marker (MM) was born to fill this need. MM is a precision health company, built by a team of multidisciplinary scientists who are trained in environmental epidemiology, toxicology, analytical chemistry, biostatistics, data engineering, and business. MM's missions are to crowdsource and scale the biomonitoring of environmental chemicals and provide actionable results to consumers in a timely manner in order to empower individuals to proactively assess, track, and reduce their harmful environmental exposures. Starting with a few biomarkers of common EDCs, MM's ultimate vision is to discover all possible ("a million") biomarkers of harmful exposures to inform and improve individual health outcomes and advance precision medicine. Less than a year after it was founded, Million Marker developed and sold the first product-a mail-in urine test for BPA and phthalates-and successfully helped users reduce exposures through personalized intervention plans. Customers are able to order a test kit online, receive the test kit via mail, take a comprehensive exposure survey (via the Million Marker app), send back samples via mail, view personalized reports with tailored product recommendations through a secure online portal, make lifestyle changes to reduce exposures, and retest to monitor progress. MM's initial target audience are individuals of reproductive age, due to the vulnerability pregnancy and preconception to EDC exposures. However, it is unclear to what extent the MM platform educates, motivates, and ultimately reduces EDC exposure in individuals in this age range. Therefore, the aims of the current proposal are to 1) test and validate a this first-of-its-kind mobile EDC reduction program in a prospective longitudinal cohort intervention trial; 2) assess changes in participants' environmental health literacy, attitudes, knowledge, and behaviors after using MM's products and services; and 3) evaluate the MM app and platform usability to improve the user experience. Validating this population with MM's program is a step towards these types of future studies. At the conclusion of the project, MM will be well-positioned to begin Phase II and will scale the EDCs testing and personalized intervention plan to fertility clinics and the general public.

03

Conditions studied

  • Endocrine Disrupting Chemicals
  • Environmental Exposure
  • Health Literacy
  • Bisphenol A
  • Phthalate Exposure
  • Survey

Browse trials for

Keywords

  • parabens
  • exposure
  • environment
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ages 18-40 years
  • in good health, not pregnant, free from diabetes or known kidney disease or cancer (these conditions may interfere with EDC metabolism)
  • able to understand written and spoken English
  • already consented for re-contact with the Healthy Nevada Project
  • owning a smartphone
  • willing to complete all study assessments

Exclusion criteria

Exclusion Criteria:

  • only one woman and her partner per household will be enrolled
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
434 participants (actual)

Study arms

  • Experimental
    Mobile EDC reduction program

    Million Marker's (MM) first-of-its-kind mobile endocrine disrupting chemical (EDC) reduction program will be tested and validated in a prospective longitudinal cohort intervention trial. 50 women in reproductive age and their partners will be recruited from the Healthy Nevada Project, an existing state-wide health monitoring effort. Using MM's services, participants' urine samples will be collected two times (at pre- and post-intervention) to measure changes in EDC levels. Changes in participants' environmental health literacy, attitudes, knowledge, and behaviors will be assessed after using MM's products and services. Validated surveys on environmental health literacy and readiness to change and analyses of participants' lifestyle behaviors and product use will be conducted at baseline (first test) and upon completion of the second test. The investigators will evaluate the MM app and platform usability to improve the user experience, using the System Usability Score (SUS) survey.

    Diagnostic Test: Mail-in Urine Test for EDCs

Interventions

  • Diagnostic testMail-in Urine Test for EDCs

    Million Marker provides a mail-in urine test for Bisphenol A (BPA) and phthalates. Users take a comprehensive exposure survey (via the MM app), send back their samples, view their personalized reports with tailored product recommendations, make changes to reduce their exposures, and retest to monitor their progress. Participants will also fill out surveys to assess changes in their environmental health literacy, readiness to change, and analyses of lifestyle behaviors and product use.

    Also known as: Million Marker Detect and Detox test kit

06

What researchers measure

Primary outcomes

  1. Changes in Endocrine Disrupting Chemical (EDC) Levels as Measured by the Post-intervention Value Minus the Baseline Value.

    Urine samples collected pre- and post-intervention to measure changes in EDC levels

    Time frame: Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention

Secondary outcomes

  1. Changes in Environmental Health Literacy Using the Environmental Literacy Survey

    Validated survey on environmental health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes. The EHL survey was adapted from the "General Environmental Health Scale" and was titled "Environmental Health Literacy Scale" with three subscales: knowledge, attitudes, and behaviors. Knowledge and attitude responses ranged from strongly disagree (1) to strongly agree (5) and behavior responses ranged from never (1) to always (5). Scores were summed across 3 questions within each subscale resulting in a range of 3 (worse) to 15 (better) for each subscale.

    Time frame: Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention. Change scores are reported as the post-intervention subscale score minus the baseline score.

07

Results

Posted May 14, 2024
Limitations and caveats
The lack of specificity and sensitivity in the EHL survey was a limitation of this study. The difficulty in assessing low levels of EDC metabolites was also a challenge, as the current EDC testing panel has high detection limits for some of the metabolites. The high attrition rate for the second urine test was also a problem, likely due to a long lag time without enough engagement and insufficient incentives.

Participant flow

Between August 2021 and July 2022, recruitment emails describing the study and asking for participation were sent to Healthy Nevada Project participants.

Participant flow — Overall Study
MilestoneMobile EDC Reduction Program
Started434
Completed50
Not completed384
Withdrew: Did not submit baseline urine test kit226
Withdrew: Lost to follow-up34
Withdrew: Did not submit second urine test kit124

Outcome measures

PrimaryChanges in Endocrine Disrupting Chemical (EDC) Levels as Measured by the Post-intervention Value Minus the Baseline Value.

Urine samples collected pre- and post-intervention to measure changes in EDC levels

Time frame:
Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention
Reported as:
Mean · ng/ml
Changes in Endocrine Disrupting Chemical (EDC) Levels as Measured by the Post-intervention Value Minus the Baseline Value.
ng/mlMobile EDC Reduction Program
methylparaben5.83 ± 156.71
propylparaben18.43 ± 105.85
monobutyl phthalate56.94 ± 117.48
monoethyl phthalate75.30 ± 556.90
mono-(2-ethyl-5-carboxypentyl) phthalate-3.47 ± 20.50
Statistical analysis
  • Mobile EDC Reduction Program · t-test, 1 sided · p = <0.05
SecondaryChanges in Environmental Health Literacy Using the Environmental Literacy Survey

Validated survey on environmental health literacy will be conducted at baseline and upon completion of the second test. The surveys will be compared for changes. The EHL survey was adapted from the "General Environmental Health Scale" and was titled "Environmental Health Literacy Scale" with three subscales: knowledge, attitudes, and behaviors. Knowledge and attitude responses ranged from strongly disagree (1) to strongly agree (5) and behavior responses ranged from never (1) to always (5). Scores were summed across 3 questions within each subscale resulting in a range of 3 (worse) to 15 (better) for each subscale.

Time frame:
Outcomes will be assessed at baseline (0-4 weeks) and up to 24 weeks for post-intervention. Change scores are reported as the post-intervention subscale score minus the baseline score.
Reported as:
Mean · units on a scale
Changes in Environmental Health Literacy Using the Environmental Literacy Survey
units on a scaleMobile EDC Reduction Program
EHL Knowledge subscale-0.16 ± 1.13
EHL attitudes subscale-0.14 ± 1.54
EHL behaviors subscale0.39 ± 1.70
Statistical analysis
  • Mobile EDC Reduction Program · paired samples t-test · p = <0.05

Adverse events

Collected over The intervention, from time of the first survey and urinalysis to the last, was typically 8 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mobile EDC Reduction Program0/434 (0%)0/434 (0%)0/434 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Mobile EDC Reduction Program
<=18 years0
Between 18 and 65 years434
>=65 years0
Age, Continuous
Age, Continuous(years)Mobile EDC Reduction Program
Mean30.7 (18 to 40)
Sex: Female, Male
Sex: Female, Male(Participants)Mobile EDC Reduction Program
Female328
Male104
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Mobile EDC Reduction Program
Asian12
Black2
Hispanic or Latino44
Native American3
Pacific Islander7
White344
Other22
Region of Enrollment
Region of Enrollment(participants)Mobile EDC Reduction Program
United States434
Baseline metabolite concentrations
Baseline metabolite concentrations(ng/ml)Mobile EDC Reduction Program
methyl paraben69.48 ± 215.69
propyl paraben22.86 ± 87.07
monobutyl phthalate71.52 ± 105.73
monoethyl phthalate151.60 ± 442.17
mono-(2-ethyl-5-carboxypentyl) phthalate5.32 ± 17.88
Environmental Health Literacy
Environmental Health Literacy(Scores on a Likert scale)Mobile EDC Reduction Program
Knowledge subscale14.32 ± 0.85
Attitudes subscale13.03 ± 1.54
Behaviors subscale12.09 ± 2.03
08

Study locations

1 site
  • Million Marker Wellness Inc.
    Berkeley, California 94704, United States
09

References and documents

Publications

  • Bowes DA, Halden RU. Breast Cancer and Dietary Intake of Endocrine Disruptors: a Review of Recent Literature. Curr. Pathobiol. Rep. 2019; 7:41-46.
  • Hiatt RA, Brody JG. Environmental Determinants of Breast Cancer. Annu Rev Public Health. 2018 Apr 1;39:113-133. doi: 10.1146/annurev-publhealth-040617-014101. Epub 2018 Jan 12. PubMed 29328875 ↗
  • Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, Nadal A, Palanza P, Panzica G, Sargis R, Vandenberg LN, Vom Saal F. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017 Mar;68:3-33. doi: 10.1016/j.reprotox.2016.10.001. Epub 2016 Oct 17. PubMed 27760374 ↗
  • Hwang S, Lim JE, Choi Y, Jee SH. Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis. BMC Endocr Disord. 2018 Nov 6;18(1):81. doi: 10.1186/s12902-018-0310-y. PubMed 30400886 ↗
  • Ghayda RA, Williams PL, Chavarro JE, Ford JB, Souter I, Calafat AM, Hauser R, Minguez-Alarcon L. Urinary bisphenol S concentrations: Potential predictors of and associations with semen quality parameters among men attending a fertility center. Environ Int. 2019 Oct;131:105050. doi: 10.1016/j.envint.2019.105050. Epub 2019 Jul 31. PubMed 31376593 ↗
  • Machtinger R, Gaskins AJ, Racowsky C, Mansur A, Adir M, Baccarelli AA, Calafat AM, Hauser R. Urinary concentrations of biomarkers of phthalates and phthalate alternatives and IVF outcomes. Environ Int. 2018 Feb;111:23-31. doi: 10.1016/j.envint.2017.11.011. Epub 2017 Nov 20. PubMed 29161633 ↗
  • Braun JM. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol. 2017 Mar;13(3):161-173. doi: 10.1038/nrendo.2016.186. Epub 2016 Nov 18. PubMed 27857130 ↗
  • Mustieles V, Zhang Y, Yland J, Braun JM, Williams PL, Wylie BJ, Attaman JA, Ford JB, Azevedo A, Calafat AM, Hauser R, Messerlian C. Maternal and paternal preconception exposure to phenols and preterm birth. Environ Int. 2020 Apr;137:105523. doi: 10.1016/j.envint.2020.105523. Epub 2020 Feb 29. PubMed 32120140 ↗
  • Woods MM, Lanphear BP, Braun JM, McCandless LC. Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study. Environ Health. 2017 Oct 27;16(1):115. doi: 10.1186/s12940-017-0332-3. PubMed 29078782 ↗
  • Veiga-Lopez A, Kannan K, Liao C, Ye W, Domino SE, Padmanabhan V. Gender-Specific Effects on Gestational Length and Birth Weight by Early Pregnancy BPA Exposure. J Clin Endocrinol Metab. 2015 Nov;100(11):E1394-403. doi: 10.1210/jc.2015-1724. Epub 2015 Sep 25. PubMed 26406292 ↗
  • Raghavan R, Romano ME, Karagas MR, Penna FJ. Pharmacologic and Environmental Endocrine Disruptors in the Pathogenesis of Hypospadias: a Review. Curr Environ Health Rep. 2018 Dec;5(4):499-511. doi: 10.1007/s40572-018-0214-z. PubMed 30578470 ↗
  • Gascon M, Casas M, Morales E, Valvi D, Ballesteros-Gomez A, Luque N, Rubio S, Monfort N, Ventura R, Martinez D, Sunyer J, Vrijheid M. Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. J Allergy Clin Immunol. 2015 Feb;135(2):370-8. doi: 10.1016/j.jaci.2014.09.030. Epub 2014 Oct 30. PubMed 25445825 ↗
  • Paciencia I, Cavaleiro Rufo J, Silva D, Martins C, Mendes F, Farraia M, Delgado L, de Oliveira Fernandes E, Padrao P, Moreira P, Severo M, Barros H, Moreira A. Exposure to indoor endocrine-disrupting chemicals and childhood asthma and obesity. Allergy. 2019 Jul;74(7):1277-1291. doi: 10.1111/all.13740. Epub 2019 Mar 5. PubMed 30740706 ↗
  • Kalkbrenner AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr Probl Pediatr Adolesc Health Care. 2014 Nov;44(10):277-318. doi: 10.1016/j.cppeds.2014.06.001. Epub 2014 Sep 5. PubMed 25199954 ↗
  • Oulhote Y, Lanphear B, Braun JM, Webster GM, Arbuckle TE, Etzel T, Forget-Dubois N, Seguin JR, Bouchard MF, MacFarlane A, Ouellet E, Fraser W, Muckle G. Gestational Exposures to Phthalates and Folic Acid, and Autistic Traits in Canadian Children. Environ Health Perspect. 2020 Feb;128(2):27004. doi: 10.1289/EHP5621. Epub 2020 Feb 19. PubMed 32073305 ↗
  • Gutierrez-Torres DS, Barraza-Villarreal A, Hernandez-Cadena L, Escamilla-Nunez C, Romieu I. Prenatal Exposure to Endocrine Disruptors and Cardiometabolic Risk in Preschoolers: A Systematic Review Based on Cohort Studies. Ann Glob Health. 2018 Jul 27;84(2):239-249. doi: 10.29024/aogh.911. PubMed 30873814 ↗
  • American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Reducing Prenatal Exposure to Toxic Environmental Agents: ACOG Committee Opinion, Number 832. Obstet Gynecol. 2021 Jul 1;138(1):e40-e54. doi: 10.1097/AOG.0000000000004449. PubMed 34259492 ↗
  • NCHS. National Health and Nutrition Examination Survey Overview. 2020. https://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/NHANES_Overview_Brochure.pdf
  • Birnbaum LS, Jung P. From endocrine disruptors to nanomaterials: advancing our understanding of environmental health to protect public health. Health Aff (Millwood). 2011 May;30(5):814-22. doi: 10.1377/hlthaff.2010.1225. PubMed 21555467 ↗
  • Walker DI, Valvi D, Rothman N, Lan Q, Miller GW, Jones DP. The metabolome: A key measure for exposome research in epidemiology. Curr Epidemiol Rep. 2019;6:93-103. Epub 2019 Apr 26. PubMed 31828002 ↗
  • Google. Google Trends 'Chemical Free' 2004-present. 2020. https://trends.google.com/trends/explore?date=all&geo=US&q=%2Fm%2F09gd7dm
  • Rock Health. Healthcare consumers in a digital transition. Results from our third national consumer survey (2017 data) on digital health adoption and sentiments. 2020. https://rockhealth.com/reports/healthcare-consumers-in-a-digital-transition/
  • Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science. 2010 Oct 22;330(6003):460-1. doi: 10.1126/science.1192603. PubMed 20966241 ↗
  • Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011 Jul;41(6):158-76. doi: 10.1016/j.cppeds.2011.01.001. PubMed 21684471 ↗
  • Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1847-50. doi: 10.1158/1055-9965.EPI-05-0456. No abstract available. PubMed 16103423 ↗
  • Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012 Feb;41(1):24-32. doi: 10.1093/ije/dyr236. Epub 2012 Jan 31. No abstract available. PubMed 22296988 ↗
  • CDC. NHANES: National Health and Nutrition Examination Survey. 2020. https://www.cdc.gov/nchs/nhanes/index.htm
  • CDC. State Biomonitoring Programs. National Biomonitoring Program. 2019. https://www.cdc.gov/biomonitoring/state_grants.html
  • CDC. Updated Tables, January 2019. National Report on Human Exposure to Environmental Chemicals. 2019. https://www.cdc.gov/exposurereport/index.html
  • CDC. National Center for Health Statistics National Health and Nutrition Examination Survey Overview. https://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/NHANES_Overview_Brochure.pdf.
  • Dennis KK, Marder E, Balshaw DM, Cui Y, Lynes MA, Patti GJ, Rappaport SM, Shaughnessy DT, Vrijheid M, Barr DB. Biomonitoring in the Era of the Exposome. Environ Health Perspect. 2017 Apr;125(4):502-510. doi: 10.1289/EHP474. Epub 2016 Jul 6. PubMed 27385067 ↗
  • Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol. 2013 Dec;42:132-55. doi: 10.1016/j.reprotox.2013.08.008. Epub 2013 Aug 30. PubMed 23994667 ↗
  • Paulose T, Speroni L, Sonnenschein C, Soto AM. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Reprod Toxicol. 2015 Jul;54:58-65. doi: 10.1016/j.reprotox.2014.09.012. Epub 2014 Sep 30. PubMed 25277313 ↗
  • Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, Cirillo F, Deodati A, Fabbrizi E, Fanos V, Gargano G, Grossi E, Iughetti L, Lazzeroni P, Mantovani A, Migliore L, Palanza P, Panzica G, Papini AM, Parmigiani S, Predieri B, Sartori C, Tridenti G, Amarri S. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting. Int J Mol Sci. 2018 Jun 2;19(6):1647. doi: 10.3390/ijms19061647. PubMed 29865233 ↗
  • Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016 Jul;4(4):565-72. doi: 10.1111/andr.12178. Epub 2016 Mar 22. PubMed 27003928 ↗
  • CDC. Bisphenol A (BPA) Factsheet. National Biomonitoring Program. 2017. https://www.cdc.gov/biomonitoring/BisphenolA_FactSheet.html
  • Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, She J, Gavin Q, Zahedi R, Bradman A, Eskenazi B, Parra KL. Reducing Phthalate, Paraben, and Phenol Exposure from Personal Care Products in Adolescent Girls: Findings from the HERMOSA Intervention Study. Environ Health Perspect. 2016 Oct;124(10):1600-1607. doi: 10.1289/ehp.1510514. Epub 2016 Mar 7. PubMed 26947464 ↗
  • Kelley AS, Banker M, Goodrich JM, Dolinoy DC, Burant C, Domino SE, Smith YR, Song PXK, Padmanabhan V. Early pregnancy exposure to endocrine disrupting chemical mixtures are associated with inflammatory changes in maternal and neonatal circulation. Sci Rep. 2019 Apr 1;9(1):5422. doi: 10.1038/s41598-019-41134-z. PubMed 30931951 ↗
  • Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon JP, Myers JP, DiGangi J, Zoeller RT, Trasande L. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 2016 Dec;4(12):996-1003. doi: 10.1016/S2213-8587(16)30275-3. Epub 2016 Oct 17. PubMed 27765541 ↗
  • WHO. Human Biomonitoring: Facts and Figures. 2015. http://www.euro.who.int/__data/assets/pdf_file/0020/276311/Human-biomonitoring-facts-figures-en.pdf
  • Bocato MZ, Bianchi Ximenez JP, Hoffmann C, Barbosa F. An overview of the current progress, challenges, and prospects of human biomonitoring and exposome studies. J Toxicol Environ Health B Crit Rev. 2019;22(5-6):131-156. doi: 10.1080/10937404.2019.1661588. Epub 2019 Sep 5. PubMed 31543064 ↗
  • Pew Research Center. Mobile Fact Sheet. Internet & Technology. 2019. https://www.pewresearch.org/internet/fact-sheet/mobile/
  • Apple Inc. App Store. 2020. https://www.apple.com/ios/app-store/
  • Google. Google Play Store. 2020. https://play.google.com/store?hl=en_US
  • Han M, Lee E. Effectiveness of Mobile Health Application Use to Improve Health Behavior Changes: A Systematic Review of Randomized Controlled Trials. Healthc Inform Res. 2018 Jul;24(3):207-226. doi: 10.4258/hir.2018.24.3.207. Epub 2018 Jul 31. PubMed 30109154 ↗
  • Sawesi S, Rashrash M, Phalakornkule K, Carpenter JS, Jones JF. The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature. JMIR Med Inform. 2016 Jan 21;4(1):e1. doi: 10.2196/medinform.4514. PubMed 26795082 ↗
  • Michie S, Yardley L, West R, Patrick K, Greaves F. Developing and Evaluating Digital Interventions to Promote Behavior Change in Health and Health Care: Recommendations Resulting From an International Workshop. J Med Internet Res. 2017 Jun 29;19(6):e232. doi: 10.2196/jmir.7126. PubMed 28663162 ↗
  • Partridge SR, Redfern J. Strategies to Engage Adolescents in Digital Health Interventions for Obesity Prevention and Management. Healthcare (Basel). 2018 Jun 21;6(3):70. doi: 10.3390/healthcare6030070. PubMed 29933550 ↗
  • Milne-Ives M, Lam C, Van Velthoven MH, Meinert E. Mobile Apps for Health Behavior Change: Protocol for a Systematic Review. JMIR Res Protoc. 2020 Jan 30;9(1):e16931. doi: 10.2196/16931. PubMed 32012109 ↗
  • Oikonomidi T, Vivot A, Tran VT, Riveros C, Robin E, Ravaud P. A Methodologic Systematic Review of Mobile Health Behavior Change Randomized Trials. Am J Prev Med. 2019 Dec;57(6):836-843. doi: 10.1016/j.amepre.2019.07.008. PubMed 31753266 ↗
  • Carwile JL, Ye X, Zhou X, Calafat AM, Michels KB. Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA. 2011 Nov 23;306(20):2218-20. doi: 10.1001/jama.2011.1721. No abstract available. PubMed 22110104 ↗
  • Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, Rizzo J, Nudelman JL, Brody JG. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect. 2011 Jul;119(7):914-20. doi: 10.1289/ehp.1003170. Epub 2011 Mar 30. PubMed 21450549 ↗
  • Peng CY, Tsai EM, Kao TH, Lai TC, Liang SS, Chiu CC, Wang TN. Canned food intake and urinary bisphenol a concentrations: a randomized crossover intervention study. Environ Sci Pollut Res Int. 2019 Sep;26(27):27999-28009. doi: 10.1007/s11356-019-05534-y. Epub 2019 Jul 27. PubMed 31352597 ↗
  • Ji K, Lim Kho Y, Park Y, Choi K. Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: a pilot study with "Temple Stay" participants. Environ Res. 2010 May;110(4):375-82. doi: 10.1016/j.envres.2010.02.008. Epub 2010 Mar 12. PubMed 20227070 ↗
  • Chen CY, Chou YY, Lin SJ, Lee CC. Developing an intervention strategy to reduce phthalate exposure in Taiwanese girls. Sci Total Environ. 2015 Jun 1;517:125-31. doi: 10.1016/j.scitotenv.2015.02.021. Epub 2015 Feb 25. PubMed 25725197 ↗
  • Sathyanarayana S, Alcedo G, Saelens BE, Zhou C, Dills RL, Yu J, Lanphear B. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J Expo Sci Environ Epidemiol. 2013 Jul;23(4):378-84. doi: 10.1038/jes.2013.9. Epub 2013 Feb 27. PubMed 23443238 ↗
  • Guo W, Huen K, Park JS, Petreas M, Crispo Smith S, Block G, Holland N. Vitamin C intervention may lower the levels of persistent organic pollutants in blood of healthy women - A pilot study. Food Chem Toxicol. 2016 Jun;92:197-204. doi: 10.1016/j.fct.2016.04.006. Epub 2016 Apr 23. PubMed 27090108 ↗
  • Correia-Sa L, Kasper-Sonnenberg M, Palmke C, Schutze A, Norberto S, Calhau C, Domingues VF, Koch HM. Obesity or diet? Levels and determinants of phthalate body burden - A case study on Portuguese children. Int J Hyg Environ Health. 2018 Apr;221(3):519-530. doi: 10.1016/j.ijheh.2018.02.001. Epub 2018 Feb 6. PubMed 29454883 ↗
  • Galloway TS, Baglin N, Lee BP, Kocur AL, Shepherd MH, Steele AM; BPA Schools Study Consortium; Harries LW. An engaged research study to assess the effect of a 'real-world' dietary intervention on urinary bisphenol A (BPA) levels in teenagers. BMJ Open. 2018 Feb 3;8(2):e018742. doi: 10.1136/bmjopen-2017-018742. PubMed 29431133 ↗
  • Hagobian T, Smouse A, Streeter M, Wurst C, Schaffner A, Phelan S. Randomized Intervention Trial to Decrease Bisphenol A Urine Concentrations in Women: Pilot Study. J Womens Health (Larchmt). 2017 Feb;26(2):128-132. doi: 10.1089/jwh.2016.5746. Epub 2016 Oct 11. PubMed 27726525 ↗
  • Hyland C, Bradman A, Gerona R, Patton S, Zakharevich I, Gunier RB, Klein K. Organic diet intervention significantly reduces urinary pesticide levels in U.S. children and adults. Environ Res. 2019 Apr;171:568-575. doi: 10.1016/j.envres.2019.01.024. Epub 2019 Feb 12. PubMed 30765100 ↗
  • Ackerman JM, Dodson RE, Engel CL, Gray JM, Rudel RA. Temporal variability of urinary di(2-ethylhexyl) phthalate metabolites during a dietary intervention study. J Expo Sci Environ Epidemiol. 2014 Nov;24(6):595-601. doi: 10.1038/jes.2013.93. Epub 2014 Jan 22. PubMed 24448002 ↗
  • Grzymski, J. J. et al. The Healthy Nevada Project: rapid recruitment for population health study. 2018. http://biorxiv.org/lookup/doi/10.1101/250274. doi:10.1101/250274.
  • Healthy Nevada Project. About Us. https://healthynv.org/about/.
  • CDC. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2019, Volume 2. 2019. https://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Volume2_Jan2019-508.pdf
  • Lehmler HJ, Liu B, Gadogbe M, Bao W. Exposure to Bisphenol A, Bisphenol F, and Bisphenol S in U.S. Adults and Children: The National Health and Nutrition Examination Survey 2013-2014. ACS Omega. 2018 Jun 30;3(6):6523-6532. doi: 10.1021/acsomega.8b00824. Epub 2018 Jun 18. PubMed 29978145 ↗
  • Meeker JD, Ferguson KK. Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012. J Clin Endocrinol Metab. 2014 Nov;99(11):4346-52. doi: 10.1210/jc.2014-2555. Epub 2014 Aug 14. PubMed 25121464 ↗
  • Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect. 2010 May;118(5):679-85. doi: 10.1289/ehp.0901560. Epub 2010 Jan 4. PubMed 20056562 ↗
  • Calafat AM, Wong LY, Ye X, Reidy JA, Needham LL. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003--2004. Environ Health Perspect. 2008 Jul;116(7):893-7. doi: 10.1289/ehp.11269. PubMed 18629311 ↗
  • Lichtveld MY, Covert HH, Sherman M, Shankar A, Wickliffe JK, Alcala CS. Advancing Environmental Health Literacy: Validated Scales of General Environmental Health and Environmental Media-Specific Knowledge, Attitudes and Behaviors. Int J Environ Res Public Health. 2019 Oct 28;16(21):4157. doi: 10.3390/ijerph16214157. PubMed 31661913 ↗
  • American Council on Exercise. Readiness to Change Questionnaire. 2014.
  • van der Vaart R, Drossaert C. Development of the Digital Health Literacy Instrument: Measuring a Broad Spectrum of Health 1.0 and Health 2.0 Skills. J Med Internet Res. 2017 Jan 24;19(1):e27. doi: 10.2196/jmir.6709. PubMed 28119275 ↗
  • U.S. Department of Health and Human Services. System Usability Scale (SUS). 2020. https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Million Marker will disseminate research results and findings to the scientific community through presentations at scientific meetings and conferences and publications in academic journals, as well as through the mass media and online postings. The Principal Investigator of this study will make data and associated documentation/metadata available to external researchers under a data-sharing agreement in which a specific commitment is made to use the data for research purposes only, to not provide the data to a third party or distribute it in any form, and to properly acknowledge the source of funding for the collection of the data and the researchers involved in this study.

Time frame: Starting 6 months after publication

Access criteria: Researchers must submit an acceptable research plan (goals of the proposed research, the specific hypotheses to be examined, justification for research and methods), be affiliated with a recognized research institution, have demonstrated expertise in the area of the proposed research project, and receive independent approval from their governing institutional review board. Data will be available for use only to answer the specific question(s) indicated in the research plan. The researchers must provide a list of variable names and an outline of how research findings will be disseminated; and will be asked to sign a data-sharing agreement that commits to: 1) not attempt to identify any individual participant, 2) secure the data using appropriate software technology, 3) and destroy or return all data once analyses are complete. All final datasets will be de-identified. Final authorship on manuscripts will require review and approval by the Principal Investigators of this study.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2022 to primary completion in Oct 2022, 5 months.

Results were first posted in May 2024, 1 year 6 months after primary completion.

Of 119 interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 19. This study's 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2023
First posted
Mar 22, 2023
StartActual
May 1, 2022
Primary completionActual
Oct 31, 2022
CompletionActual
Oct 31, 2022
Results first posted
May 14, 2024
Last update
May 14, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05780047
Lead sponsor
Million Marker Wellness, Inc.
Responsible party
Sponsor
First posted
Mar 22, 2023
Start date
May 1, 2022
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Results posted
May 14, 2024
Last update
May 14, 2024

Study contacts

Jenna Hua, PhD
principal investigator · Million Marker Wellness, Inc.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion